Question 1

Does Citigroup own CUE stock?

Accepted Answer

No. Citigroup exited its CUE (Cue Biopharma) position in Q4 2025. Its Q3 2025 13F listed 132 shares worth $95.

Question 2

How many shares of CUE does Citigroup own?

Accepted Answer

None since Q4 2025, when Citigroup exited the position. Its Q3 2025 13F listed 132 shares worth $95.

Question 3

What is Citigroup's CUE position worth?

Accepted Answer

Citigroup's CUE position was worth $95 in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Citigroup buying or selling CUE?

Accepted Answer

In Q4 2025, Citigroup exited its entire CUE position.

Question 5

When did Citigroup first buy CUE?

Accepted Answer

Citigroup already held CUE in its Q4 2023 13F, the earliest on record, and listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$9.15	0
2025-Q3	New	132	—	$95	0.0%	$21.57	17
2025-Q1	Exited	0	-100.0%	$0	0.0%	$27.33	0
2024-Q4	Unchanged	43	0.0%	$47	0.0%	$32.70	0
2024-Q3	Decreased	43	-99.2%	$33	0.0%	$22.71	0